推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Acta Pharmaceutica Sinica B

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 ACTA PHARM SIN 最新评论:大家with editor多久啊,怎么十几天还没动静 (2024-06-18)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Acta Pharmaceutica Sinica B期刊基本信息Hello,您是该期刊的第179474位访客

基本信息 登录收藏
期刊名字Acta Pharmaceutica Sinica BActa Pharmaceutica Sinica B

ACTA PHARM SIN B
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
8.3
76人评分
我要评分

声誉
8.9

影响力
7.6

速度
8.7

期刊ISSN2211-3835
微信扫码收藏此期刊
E-ISSN2211-3843
2022-2023最新影响因子
(数据来源于搜索引擎)
14.5 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:14.392
2022-2023自引率5.50%点击查看自引率趋势图
五年影响因子13.2
h-index 28
CiteScore
CiteScoreSJRSNIPCiteScore排名
22.403.0352.253
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:General Pharmacology, Toxicology and Pharmaceutics
Q11 / 80

期刊简介
Acta Pharmaceutica Sinica B (APSB) is a bimonthly journal, in English, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences — including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.
期刊官方网站https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b
期刊投稿网址https://www.editorialmanager.com/APSB
期刊语言要求Language
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Acta Pharmaceutica Sinica B的语言要求,还能让Acta Pharmaceutica Sinica B编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Acta Pharmaceutica Sinica B编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(2篇) 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:没有
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:pharmaceutical science、traditional chinese medicine、pharmaceutics、pharmaceutical chemistry、pharmacokinetics
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式C/O EDITORIAL BOARD OF ACTA PHARMACEUTICA SINICA, 1 XIANNONGTAN ST, BEIJING, PEOPLES R CHINA, 100050
出版商Elsevier BV
涉及的研究方向Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
出版国家或地区Netherlands
出版语言English
出版周期
出版年份0
年文章数 281点击查看年文章数趋势图
Gold OA文章占比92.43%
研究类文章占比:
文章 ÷(文章 + 综述)
75.80%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:PHARMACOLOGY & PHARMACY
类别:SCIE
Q15/277
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区1区3区
PHARMACOLOGY & PHARMACY
药学
1区1区1区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
化学 3区1区2区
PHARMACOLOGY & PHARMACY
药学
1区2区1区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
化学 3区1区4区
PHARMACOLOGY & PHARMACY
药学
4区4区1区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2211-3835%5BISSN%5D
平均审稿速度网友分享经验:
19 Weeks
平均录用比例网友分享经验:
版面费/APC文章处理费信息
文章处理费:没有
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Acta Pharmaceutica Sinica B顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Acta Pharmaceutica Sinica B期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Acta Pharmaceutica Sinica B中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Acta Pharmaceutica Sinica B上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Antibiotics-Basel07.30
    Therapeutics and Clinical Risk Management05.30
    Pharmacology Research & Perspectives05.30
    Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy372.60
    Infarma Pharmaceutical Sciences00.10
    Mental Health Clinician01.90
    Pharmacological Research Modern Chinese Medicine01.60
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE625633
    BIOMATERIALS531182
    BIOMEDICINE & PHARMACOTHERAPY491859
    Journal of Materials Chemistry B473380
    Frontiers in Pharmacology472197
    Frontiers in Immunology445392
    JOURNAL OF ETHNOPHARMACOLOGY424735
    COLLOIDS AND SURFACES B-BIOINTERFACES415514
    COMPUTERS IN BIOLOGY AND MEDICINE404346
    Frontiers in Oncology401943
  •  

    Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Late-stage cascade of oxidation reactions during the biosynthesis of oxalicine B in Penicillium oxalicum

    Author: Zhang, Tao; Gu, Guowei; Liu, Guodong; Su, Jinhua; Zhan, Zhilai; Zhao, Jianyuan; Qian, Jinxiu; Cai, Guowei; Cen, Shan; Zhang, Dewu; Yu, Liyan
    Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 256-270. DOI: 10.1016/j.apsb.2022.09.008
        PubMed      DOI
    2.Actively separated microneedle patch for sustained-release of growth hormone to treat growth hormone deficiency

    Author: Yang, Li; Liu, Qingyun; Wang, Xinhui; Gao, Nansha; Li, Xiuzhen; Chen, Hongzhong; Mei, Lin; Zeng, Xiaowei
    Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 344-358. DOI: 10.1016/j.apsb.2022.04.015
        PubMed      DOI
    3.Dihydrotanshinone I preconditions myocardium against ischemic injury via PKM2 glutathionylation sensitive to ROS

    Author: Wu, Xunxun; Liu, Lian; Zheng, Qiuling; Ye, Hui; Yang, Hua; Hao, Haiping; Li, Ping
    Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 113-127. DOI: 10.1016/j.apsb.2022.07.006
        PubMed      DOI
    4.Chlorella sp.-ameliorated undesirable microenvironment promotes diabetic wound healing

    Author: Wu, Hangyi; Yang, Pei; Li, Aiqin; Jin, Xin; Zhang, Zhenhai; Lv, HuiXia
    Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 410-424. DOI: 10.1016/j.apsb.2022.06.012
        PubMed      DOI
    5.Bilayer hydrogel dressing with lysozyme-enhanced photothermal therapy for biofilm eradication and accelerated chronic wound repair

    Author: Wang, Yizhen; Lv, Qijun; Chen, You; Xu, Langtao; Feng, Miao; Xiong, Zhiyong; Li, Jiajun; Ren, Jie; Liu, Jie; Liu, Bo
    Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 284-297. DOI: 10.1016/j.apsb.2022.03.024
        PubMed      DOI
    6.PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism

    Author: Sun, Mingming; Li, Leilei; Niu, Yujia; Wang, Yingzhi; Yan, Qi; Xie, Fei; Qiao, Yaya; Song, Jiaqi; Sun, Huanran; Li, Zhen; Lai, Sizhen; Chang, Hongkai; Zhang, Han; Wang, Jiyan; Yang, Chenxin; Zhao, Huifang; Tan, Junzhen; Li, Yanping; Liu, Shuangping; Lu, Bin; Liu, Min; Kong, Guangyao; Zhao, Yujun; Zhang, Chunze; Lin, Shu-Hai; Luo, Cheng; Zhang, Shuai; Shan, Changliang
    Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 157-173. DOI: 10.1016/j.apsb.2022.05.019
        PubMed      DOI
    7.Sialic acid-mediated photochemotherapy enhances infiltration of CD8D T cells from tumor-draining lymph nodes into tumors of immunosenescent mice

    Author: Sui, Dezhi; Li, Changzhi; Tang, Xueying; Meng, Xianmin; Ding, Junqiang; Yang, Qiongfen; Qi, Zhaowei; Liu, Xinrong; Deng, Yihui; Song, Yanzhi
    Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 425-439. DOI: 10.1016/j.apsb.2022.06.005
        PubMed      DOI
    8.Pathologically triggered in situ aggregation of nanoparticles for inflammation-targeting amplification and therapeutic potentiation

    Author: Nie, Qiang; Li, Chenwen; Wang, Yu; Hu, Yi; Pu, Wendan; Zhang, Qixiong; Cai, Jiajun; Lin, Yongyao; Li, Gang; Wang, Chenping; Li, Lanlan; Dou, Yin; Zhang, Jianxiang
    Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 390-409. DOI: 10.1016/j.apsb.2022.07.013
        PubMed      DOI
    9.All-stage targeted therapy for the brain metastasis from triple-negative breast cancer

    Author: Luo, Zimiao; Wu, Sunyi; Zhou, Jianfen; Xu, Weixia; Xu, Qianzhu; Lu, Linwei; Xie, Cao; Liu, Yu; Lu, Weiyue
    Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 359-371. DOI: 10.1016/j.apsb.2022.03.0262211-3835
        PubMed      DOI
    10.Macrophage-evading and tumor-specific apoptosis inducing nanoparticles for targeted cancer therapy

    Author: Liu, Zimo; Zhou, Xuefei; Li, Qi; Shen, Youqing; Zhou, Tianhua; Liu, Xiangrui
    Journal: ACTA PHARMACEUTICA SINICA B. 2023; Vol. 13, Issue 1, pp. 327-343. DOI: 10.1016/j.apsb.2022.05.010
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62248.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    NATURE MEDICINE497100.90
    Nature Reviews Disease Primers4876.70
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62248.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386173.60
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    NATURE REVIEWS MICROBIOLOGY25074.00
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共191条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室